Column Group IV GP, LP

Insider Reports History

Location
San Francisco, CA
Signature
/s/ The Column Group IV GP, LP, /s/ James Evangelista, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Column Group IV GP, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 4,312,139 06 Feb 2026 By The Column Group IV, LP
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 1,319,164 06 Feb 2026 By The Column Group Opportunity III, LP
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 148,840 06 Feb 2026 By The Column Group IV-A, LP
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 3,352 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Feb 2026 By The Column Group IV-A, LP
Eikon Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Feb 2026 By The Column Group IV, LP
Eikon Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 06 Feb 2026 By The Column Group IV-A, LP
Eikon Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 06 Feb 2026 By The Column Group IV, LP
Eikon Therapeutics, Inc. 10%+ Owner Series C-1 Preferred Stock 0 06 Feb 2026 By The Column Group IV-A, LP
Eikon Therapeutics, Inc. 10%+ Owner Series C-1 Preferred Stock 0 06 Feb 2026 By The Column Group IV, LP
Eikon Therapeutics, Inc. 10%+ Owner Series D Preferred Stock 0 06 Feb 2026 By The Column Group Opportunity III, LP

Insider Reports Filed by Column Group IV GP, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EIKN Eikon Therapeutics, Inc. 06 Feb 2026 17 +$38,119,680 4 10%+ Owner 09 Feb 2026, 21:19
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 0 $0 3 10%+ Owner 04 Feb 2026, 21:59